News

How Novo Nordisk Gave Up Its Weight-Loss Gains
Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.
Americans’ becoming more aware of GLP-1 drugs like Ozempic, Wegovy: Survey
The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...
Study Finds13d
Popular Weight Loss Drugs Like Ozempic May Cause Major Muscle Loss Without Boosting Fitness, Study Warns
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...
“Ozempic Makeovers” on the Rise: Dr. Meegan Gruber Addresses Post-Weight-Loss Skin Laxity With Awake Body Contouring
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...
Wegovy maker Novo hit with investor class action over revenue forecast cut
Novo Nordisk , maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish ...
Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
3 Minute Breakdowns on MSN2d
novo nordisk stock analysis: ozempic, wegovy, and market share - august 2025
Is Novo Nordisk stock a buy? An analysis of $NVO, its weight loss drugs Ozempic and Wegovy, and market share competition with ...